JUNE 10, 2026 AT 10:22 AM

Johnson & Johnson (JNJ) CEO says that a cure for certain cancers is a realistic goal to have over the coming decade, WSJ reports

Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.

Open Dashboard

#JOHNSON & JOHNSON#JNJ.US#EQUITIES#EU SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#JNJ#US EQUITIES